12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several healthcare stocks experienced significant movements. Regulus Therapeutics (RGLS) led the gainers with a 94.9% increase, while Lexaria Bioscience (LEXX) saw the largest decline at 30.5%. Other notable movers included Bright Green (BGXX), SCWorx (WORX), and Caribou Biosciences (CRBU), among others. The movements were attributed to various factors, including quarterly earnings reports for Viracta Therapeutics (VIRX) and Caribou Biosciences.
March 12, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Caribou Biosciences shares decreased by 24.38% to $5.46 after its Q4 earnings report.
The decline in CRBU stock price after the earnings report indicates a negative market reaction to the company's financial results.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Lexaria Bioscience stock declined by 30.5%, with a market cap of $53.7 million.
The sharp decline in LEXX stock price suggests negative sentiment or disappointing news affecting investor confidence.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Regulus Therapeutics stock surged 94.9% with a market cap of $54.3 million.
The significant increase in RGLS stock price indicates strong investor interest, potentially due to positive developments within the company.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Viracta Therapeutics stock increased by 17.96% to $1.05, following its Q4 earnings report.
The increase in VIRX stock price post-earnings suggests the market reacted positively to the company's financial performance.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80